Threat actor Hunters International is deploying a new RAT called SharpRhino, which is creating significant challenges for ...
AstraZeneca will acquire all outstanding equity of EsoBiotec for a total consideration of up to $1,000m, on a cash and debt free basis. This will include an initial payment of $425m on deal closing, ...
AstraZeneca has entered into a definitive agreement to acquire EsoBiotec, a biotechnology company pioneering in vivo cell ...
Power Metallic Inc. (the "Company" or "Power Metallic") is pleased to provide an update on the current exploration activity ...
AstraZeneca to acquire EsoBiotec to advance cell therapy ambition Acquisition includes world-leading in vivo delivery platform with potential to transform cell therapy AstraZeneca has ...
CJ ENM CEO Yoon Sang-hyun has talked his $818M content spend, Severance, Netflix and partnerships with Warner Bros.
Ahead of the SXSW premiere of 'Satisfaction', writer-director Alex Burunova and Emma Laird stopped by the Deadline Studio.
The UK drugmaker AstraZeneca has agreed to acquire Belgian cell therapy developer EsoBiotec for up to $1bn to enhance its cancer treatment capabilities. Read more.
A supply chain attack on a GitHub Actions tool has put up to 23,000 organisations at risk of having credentials stolen.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback